Literature DB >> 10829919

Autoimmune hepatitis.

E A Roberts1.   

Abstract

Autoimmune hepatitis can present as either acute or chronic disease in children. Clinical and laboratory features, including association with extrahepatic autoimmune syndromes and prompt response to immunosuppressive treatment, circulating autoantibodies and hypergammaglobulinemia, suggest an immune etiology. However, the disease mechanism remains uncertain. Different types of autoimmune hepatitis are defined on the basis of which autoantibodies are present: anti-smooth muscle (type 1), anti-liver/kidney microsomal (type 2), or anti-soluble liver antigen (type 3). Diseases which may be clinically similar to autoimmune hepatitis must be excluded before the diagnosis of autoimmune hepatitis is established: Wilson's disease, primary sclerosing cholangitis, chronic hepatitis B or C, and drug-induced liver disease are among the most important entities. Corticosteroids alone or with azathioprine constitute the usual treatment for autoimmune hepatitis. Although some children achieve a complete remission, or even recovery, and can stop immunosuppressive treatment, others required low-dose prednisone treatment indefinitely.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 10829919     DOI: 10.1007/bf02761871

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   1.967


  37 in total

1.  Maintenance of remission in autoimmune chronic active hepatitis with azathioprine after corticosteroid withdrawal.

Authors:  A J Stellon; J J Keating; P J Johnson; I G McFarlane; R Williams
Journal:  Hepatology       Date:  1988 Jul-Aug       Impact factor: 17.425

2.  Meeting report: International Autoimmune Hepatitis Group.

Authors:  P J Johnson; I G McFarlane
Journal:  Hepatology       Date:  1993-10       Impact factor: 17.425

3.  Susceptibility to autoimmune chronic active hepatitis: human leukocyte antigens DR4 and A1-B8-DR3 are independent risk factors.

Authors:  P T Donaldson; D G Doherty; K M Hayllar; I G McFarlane; P J Johnson; R Williams
Journal:  Hepatology       Date:  1991-04       Impact factor: 17.425

4.  Anti-liver-kidney microsome antibody-positive autoimmune hepatitis presenting as fulminant liver failure.

Authors:  G Porta; L C Gayotto; F Alvarez
Journal:  J Pediatr Gastroenterol Nutr       Date:  1990-07       Impact factor: 2.839

5.  Sustained remission after corticosteroid therapy of severe hepatitis B surface antigen-negative chronic active hepatitis.

Authors:  A J Czaja; S J Beaver; M T Shiels
Journal:  Gastroenterology       Date:  1987-01       Impact factor: 22.682

6.  Duration of chronic active hepatitis and the development of cirrhosis.

Authors:  A Vegnente; V F Larcher; A P Mowat; B Portmann; R Williams
Journal:  Arch Dis Child       Date:  1984-04       Impact factor: 3.791

7.  Cyclosporine treatment of autoimmune chronic active hepatitis.

Authors:  J S Hyams; M Ballow; A M Leichtner
Journal:  Gastroenterology       Date:  1987-10       Impact factor: 22.682

8.  Primary sclerosing cholangitis in childhood.

Authors:  M el-Shabrawi; M L Wilkinson; B Portmann; G Mieli-Vergani; S K Chong; R Williams; A P Mowat
Journal:  Gastroenterology       Date:  1987-05       Impact factor: 22.682

9.  Different immune mechanisms leading to autoimmunity in primary sclerosing cholangitis and autoimmune chronic active hepatitis of childhood.

Authors:  G Mieli-Vergani; A Lobo-Yeo; B M McFarlane; I G McFarlane; A P Mowat; D Vergani
Journal:  Hepatology       Date:  1989-02       Impact factor: 17.425

10.  Prognosis of Wilsonian chronic active hepatitis.

Authors:  M L Schilsky; I H Scheinberg; I Sternlieb
Journal:  Gastroenterology       Date:  1991-03       Impact factor: 22.682

View more
  3 in total

1.  Chronic Liver Diseases in Children: Clinical Profile and Histology.

Authors:  Sachin Devidas Dhole; Archana S Kher; Radha G Ghildiyal; Manjusha P Tambse
Journal:  J Clin Diagn Res       Date:  2015-07-01

2.  Involvement of (IgG and IgM)-secreting B lymphocytes in severity of autoimmune hepatitis type 1.

Authors:  Ayaid Khadem Zgair
Journal:  Med Microbiol Immunol       Date:  2013-01-08       Impact factor: 3.402

3.  Autoimmune hepatitis.

Authors:  H Ozen; N Koçak; I N Saltik; A Yüce; F Gürakan
Journal:  Indian J Pediatr       Date:  2001-08       Impact factor: 5.319

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.